Jianhua Hu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jianhua Hu has a total of 135 co-authors. Here are the top co-authors by number of shared publications:
Anthony G. Letai
10 shared publications- Daniel J. DeAngelo
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States
10 shared publications Donna Bucci
10 shared publications- Eugene Park
Eikon Therapeutics Inc., 230 Harriet Tubman Way, Millbrae 94030, California, United States
10 shared publications - Gautam Borthakur
Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, USA
10 shared publications - Guido Marcucci
Gehr Family Center for Leukemia Research, Hematology Malignancies and Stem Cell Transplantation Institute, City of Hope Medical Center, Duarte, USA
10 shared publications
Latest Publications
- Open Access
- 30 July 2026
- Published by Wolters Kluwer Health in Infectious Microbes and Diseases
- Vol. 8 (3) , 175-186
Multiomics Analysis Reveals Microbiota, Immune and Metabolomics Characteristics in COVID-19 Patients with Differing Severity
Background & aims: The COVID-19 pandemic remains a significant clinical challenge compounded by the emergence of new variants with heightened pathogenicity. This study aimed to characterize multiomics alterations in COVID-19 patients and establish an early predictive model for disease progression. Methods: We analyzed the oral and gut microbiomes, serum metabolome and immune cell profiles in 35 healthy controls and 101 COVID-19 patients with varying severity. Results: COVID-19 patients showed significant reductions in oral and gut microbial diversity, with depletion of beneficial butyrate-producing bacteria and enrichment of opportunistic pathogens like Enterococcus and Streptococcaceae. While overall microbial community structures between severity groups were similar, specific taxonomic and functional shifts were evident, such as an enrichment of oral Helicobacter ganmani and a depletion of gut Gordonibacter pamelaeae in the severe group. Serum metabolomics revealed distinct profiles, with altered lysine degradation in severe cases. Crucially, immune phenotyping demonstrated that severely ill patients had a significantly lower frequency of CD4 + PD-1 + CD69 − T cells, a subset critical for early immune homeostasis, early in the infection. In addition, a preliminary integrated predictive model integrating age, CD4 + PD-1 + CD69 − T cells and oral H. ganmani demonstrated superior discriminatory power for predicting nonsevere COVID-19 cases in the early stage with a risk of progressing to the severe stage. Conclusions: These findings highlight the critical role of early immune dysregulation and suggest that a combined microbial and immune marker approach holds significant potential for timely risk stratification in COVID-19.
- 30 July 2026
- Published by Wolters Kluwer Health in Infectious Microbes and Diseases
- Vol. 8 (3) , 175-186
Open AccessMultiomics Analysis Reveals Microbiota, Immune and Metabolomics Characteristics in COVID-19 Patients with Differing Severity
Background & aims: The COVID-19 pandemic remains a significant clinical challenge compounded by the emergence of new variants with heightened pathogenicity. This study aimed to characterize multiomics alterations in COVID-19 patients and establish an early predictive model for disease progression. Methods: We analyzed the oral and gut microbiomes, serum metabolome and immune cell profiles in 35 healthy controls and 101 COVID-19 patients with varying severity. Results: COVID-19 patients showed significant reductions in oral and gut microbial diversity, with depletion of beneficial butyrate-producing bacteria and enrichment of opportunistic pathogens like Enterococcus and Streptococcaceae. While overall microbial community structures between severity groups were similar, specific taxonomic and functional shifts were evident, such as an enrichment of oral Helicobacter ganmani and a depletion of gut Gordonibacter pamelaeae in the severe group. Serum metabolomics revealed distinct profiles, with altered lysine degradation in severe cases. Crucially, immune phenotyping demonstrated that severely ill patients had a significantly lower frequency of CD4 + PD-1 + CD69 − T cells, a subset critical for early immune homeostasis, early in the infection. In addition, a preliminary integrated predictive model integrating age, CD4 + PD-1 + CD69 − T cells and oral H. ganmani demonstrated superior discriminatory power for predicting nonsevere COVID-19 cases in the early stage with a risk of progressing to the severe stage. Conclusions: These findings highlight the critical role of early immune dysregulation and suggest that a combined microbial and immune marker approach holds significant potential for timely risk stratification in COVID-19.
- Open Access
- 22 December 2025
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 25 (1)
The prevalence and influence of EBV infection in patients with severe fever with thrombocytopenia syndrome
Severe fever with thrombocytopenia (SFTS) is a fatal emerging infectious disease. Co-infection, mainly with bacterial and fungal infections, in association
- 22 December 2025
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 25 (1)
Open AccessThe prevalence and influence of EBV infection in patients with severe fever with thrombocytopenia syndrome
Severe fever with thrombocytopenia (SFTS) is a fatal emerging infectious disease. Co-infection, mainly with bacterial and fungal infections, in association
- 14 December 2023
- Published by Zhejiang University Press in Journal of Zhejiang University-SCIENCE B
- Vol. 24 (12) , 1159-1164
Typical hemophagocytic syndrome associated with cytomegalovirus infection in an immunocompetent patient: a case report and literature review
摘要 嗜血细胞综合征是一种罕见的因大量免疫细胞不受控制的激活和增殖以及细胞因子风暴引起的致命性疾病。尽管病毒感染是其常见病因,但由巨细胞病毒引起的嗜血细胞综合征较为少见。巨细胞病毒感染通常可在免疫功能低下或缺陷人群中引起系列疾病,而在免疫功能正常人群中多表现为无症状。本文报道了一例免疫功能正常患者感染巨细胞病毒引起嗜血细胞综合征后,经芦可替尼治疗成功好转。本文旨在强调免疫功能正常患者感染巨细胞病毒后可引起严重的嗜血细胞综合征,而及时给予芦可替尼治疗可以显著改善患者预后。同时,应进一步提高临床医师对免疫功能正常人群感染巨细胞病毒的重视,并为临床工作者提供新的诊疗思路。
- 14 December 2023
- Published by Zhejiang University Press in Journal of Zhejiang University-SCIENCE B
- Vol. 24 (12) , 1159-1164
Typical hemophagocytic syndrome associated with cytomegalovirus infection in an immunocompetent patient: a case report and literature review
摘要 嗜血细胞综合征是一种罕见的因大量免疫细胞不受控制的激活和增殖以及细胞因子风暴引起的致命性疾病。尽管病毒感染是其常见病因,但由巨细胞病毒引起的嗜血细胞综合征较为少见。巨细胞病毒感染通常可在免疫功能低下或缺陷人群中引起系列疾病,而在免疫功能正常人群中多表现为无症状。本文报道了一例免疫功能正常患者感染巨细胞病毒引起嗜血细胞综合征后,经芦可替尼治疗成功好转。本文旨在强调免疫功能正常患者感染巨细胞病毒后可引起严重的嗜血细胞综合征,而及时给予芦可替尼治疗可以显著改善患者预后。同时,应进一步提高临床医师对免疫功能正常人群感染巨细胞病毒的重视,并为临床工作者提供新的诊疗思路。
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Table 2 from Selective BCL-2 Inhibition by ABT-199 Causes On-Target Cell Death in Acute Myeloid Leukemia
PDF file 118K, This table includes genetic information of the AML patients studied in this manucript
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 2 from Selective BCL-2 Inhibition by ABT-199 Causes On-Target Cell Death in Acute Myeloid Leukemia
PDF file 118K, This table includes genetic information of the AML patients studied in this manucript
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Table 1 from Selective BCL-2 Inhibition by ABT-199 Causes On-Target Cell Death in Acute Myeloid Leukemia
PDF file 222K, This includes the clinical characteristics of AML patients studied in this manuscript
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 1 from Selective BCL-2 Inhibition by ABT-199 Causes On-Target Cell Death in Acute Myeloid Leukemia
PDF file 222K, This includes the clinical characteristics of AML patients studied in this manuscript